The acquired immunodeficiency syndrome and intravenous drug abuse.

The acquired immunodeficiency syndrome and intravenous drug abuse.
复制标题

获得性免疫缺陷综合症和静脉注射药物滥用。

DOI:
--
复制
发表时间:
1988
期刊:
Bulletin on narcotics
影响因子:
--
通讯作者:
H. Haverkos
H. Haverkos
中科院分区:
--
文献类型:
--
作者:
R. Battjes;C. Leukefeld;R. Pickens;H. Haverkos

文献摘要

被引文献

相似文献

静脉注射药物滥用者占美利坚合众国成人后天免疫机能丧失综合症(艾滋病)病例的25%,占欧洲这类病例的21%。人体免疫机能丧失病毒(艾滋病毒)在静脉注射吸毒者中迅速传播的可能性是存在的,因为这类吸毒者通常共用药物注射设备。艾滋病的异性性传播和围产期传播在很大程度上也与静脉注射药物滥用有关,药物滥用者已被确定为艾滋病流行病传播的主要媒介,因为它与静脉注射药物滥用有关。只要静脉注射吸毒者上瘾,他们就将继续面临感染艾滋病的危险。因此,预防艾滋病的首要策略必须是帮助吸毒者停止使用毒品。建议应扩大药物滥用治疗资源,并制定外展方案,以鼓励更多静脉注射药物滥用者接受治疗。还必须向继续注射毒品的静脉吸毒者以及吸毒者及其性伴侣提供降低艾滋病风险的咨询,以防止艾滋病毒的性传播。现在必须采取有力的艾滋病预防举措,采用最有希望的干预战略,同时评估和完善这些战略。
Intravenous drug abusers constitute 25 per cent of the cases of the acquired immunodeficiency syndrome (AIDS) in adults in the United States of America and 21 per cent of such cases in Europe. The potential for the rapid spread of the human immunodeficiency virus (HIV) among intravenous drug abusers exists because such drug abusers commonly share drug injection equipment. The heterosexual and perinatal spread of AIDS is also largely associated with intravenous drug abusers, and drug abusers have been identified as a major vector for the spread of the AIDS epidemic as it is associated with intravenous drug abuse. As long as intravenous drug abusers are addicted, they will continue to be at risk of contracting AIDS. Thus, the primary AIDS prevention strategy must be to help addicts to stop using drugs. It is suggested that drug abuse treatment resources should be expanded and outreach programmes developed to encourage more intravenous drug abusers to enter treatment. AIDS risk-reduction counseling must also be provided to intravenous drug abusers who continue injecting drugs, and to addicts and their sexual partners to prevent the sexual spread of HIV. Vigorous AIDS prevention initiatives must be undertaken now, using the most promising intervention strategies, while simultaneously evaluating and refining these strategies.